A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck.
about
Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosisA semi-automated technique determining the liver standardized uptake value reference for tumor delineation in FDG PET-CT.Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells.Evaluation of testicular tissue of adult rats treated with cisplatin incorporated into the liposome.
P2860
A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neck.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A phase I trial of erlotinib a ...... arcinoma of the head and neck.
@ast
A phase I trial of erlotinib a ...... arcinoma of the head and neck.
@en
type
label
A phase I trial of erlotinib a ...... arcinoma of the head and neck.
@ast
A phase I trial of erlotinib a ...... arcinoma of the head and neck.
@en
prefLabel
A phase I trial of erlotinib a ...... arcinoma of the head and neck.
@ast
A phase I trial of erlotinib a ...... arcinoma of the head and neck.
@en
P2093
P2860
P1476
A phase I trial of erlotinib a ...... arcinoma of the head and neck.
@en
P2093
Arlene Forastiere
Jill Gilbert
Maura Gillison
Michaela J Higgins
Michelle A Rudek
Muhammad A Chaudhry
Nancy Tsottles
Richard Wahl
Sara Bienvenu
P2860
P304
P356
10.1158/1078-0432.CCR-11-2544
P407
P577
2012-01-23T00:00:00Z